foxo4-dri peptide senolytic 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1




